Search results for: Precision Medicine
Filter search results
Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?
16 June 2021
Our new paper explores the evidence currently being used to allocate budgets between public sector activities in the UK and its limitations. We argue that there is much that can…
Value, Affordability, and Decision Making
Value, Affordability, and Decision Making Efficient decisions about the allocation of health care budgets require the assessment of the effects of health care interventions and of the value for money…
Mireia Jofre-Bonet
8 January 2019
…London School of Hygiene & Tropical Medicine, the London School of Economics and Political Science, and the Department of Public Health of Yale University. She actively contributes to policy discussions…
Surveillance and Early Diagnosis and General Practice
1 July 1966
…extension of clinical medicine, primarily in general practice, to increase the likelihood of particular diseases being detected, whether the patient as consulted the doctor for that disease or not. These…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
Share this: Download publication Hania El Banhawi Henry Fong Matthias Hofer Lotte Steuten Compared to shorter acting therapies, long-acting therapies might be overlooked and hold potential for patients, healthcare systems…
Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
1 November 2009
…are based primarily on clinical evidence, countries are flexible in their criteria and their approach, accepting lower risk-benefit ratios for OMPs than for other new medicines. When a formal health…
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
…key activities across the lifecycle of a medicine: Epidemiology and pharmacoepidemiology: Identifying unmet need; Pharmacogenetics; Interventional studies; Non-interventional studies; Pharmacovigilance, and; Managed entry agreements. We conclude that the GDPR does…
NHS Waiting Lists: Towards the Elusive Solution
1 August 1997
…health economics, together with a drive for evidence based medicine are undoubtedly having a profound effect on the finance and organisation of the NHS. In this OHE briefing it has…
Adverse Reactions and the Community
1 November 1982
…the future. Historically, two events stand out in relation to adverse reactions to medicines. The first was the thalidomide tragedy in 1961, and the second was with practolol in the…